peter ruprecht

Peter Ruprecht (Blockchain, Technology, Magic and Photography)

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

🔴 LIVE: Are younger people aging faster? - The GoodWill Show https://t.co/X7TgNob8xY

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

🔴 LIVE: Cancer Research Worth Your Time https://t.co/yRAorVe0aD

[peter ruprecht @peterruprecht_]

@jasonwilliamsmd GLP1's are all over the news ..with good reason..they have some pretty significant results.....fascinated about the cancer angle

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

🔴 LIVE: Cancer Research Worth Your Time https://t.co/S84vu1m5dh

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

The GoodWill Show - Your Truth Source for Cancer https://t.co/wlumjJ1L7s

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

The GoodWill Show - Your Truth Source for Cancer https://t.co/X1oRmdtRth

[peter ruprecht @peterruprecht_]

@jasonwilliamsmd Great show !

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

The GoodWill Show - Your Truth Source for Cancer https://t.co/kyAqBYZlaf

[peter ruprecht @peterruprecht_]

@jasonwilliamsmd @BenSasse i thought you might be interested in this. Intratumoral Immunotherapy is the most cutting edge for stage iv pancreatic cancer. My father passed from it. so i take it in as a personal thing to let people know about it.

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

The CIA didn't hide a cancer cure. The pharmaceutical industry made it unprofitable to pursue one.

I've been using antiparasitic drugs like ivermectin and mebendazole in my cancer protocols since 2017. Not because cancer is a parasite. That's an oversimplification that leads people down the wrong path. It's because parasites and cancer cells run the same biological playbook: hijack the host, evade immune detection, replicate, spread. Drugs designed to disrupt one can hit the other.

What I've seen clinically is that these drugs, when used properly alongside immunotherapy, can extend lives that the conventional system had written off. But they're not magic bullets. Every cancer is different. Dosing matters. Combinations matter. I've also seen cases where fenbendazole appeared to accelerate tumor growth when used incorrectly. The science here requires precision.

Mebendazole has over 200 published studies showing anti-cancer activity. The evidence has been building in plain sight for years. The real question isn't why the CIA had this document. It's why drugs that cost a few dollars per dose still can't get funding for large-scale cancer trials. You already know the answer.

[peter ruprecht @peterruprecht_]

@jasonwilliamsmd Makes sense. Whatever that young state of mind is is magical

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

In our recent broadcast @drgoodyear said something that really resonated with me. He said that somewhere in the process of drug development, we've lost the humanity of the patient and the potential of what it means to be a physician to serve the patient.

He's right. And I've seen it firsthand for a long time now.

Technology and clinical innovation are moving faster than ever, but the regulatory process hasn't kept pace. Patients have access to more information than at any point in history, yet they can't access treatments that could help them because the approval pipeline is still functioning decades behind the science.

At @WmsCInstitute , we've lived this challenge. Cancer is complex. It often requires multiple drugs working together. But the FDA has traditionally required single-drug approval, which means a drug that may not show strong results on its own, but could be transformative in combination, never gets its chance. We've been working to change that. We now have a four-drug combination in clinical trials, and the FDA is beginning to open up to combination approaches. But it's been a long road.

Dr. Goodyear put it well: we need to innovate on the regulatory side to match the innovation happening on the clinical side. How do we get treatments to patients faster while maintaining safety? Because the cost of a life can't be measured in dollars, timelines, or quarterly earnings. It's measured in relationships, in time with family, in the chance to keep living.

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

Progress in Pancreatic Cancer https://t.co/6xHwRNwWj2

[peter ruprecht @peterruprecht_]

Talking about pancreatic cancer research.
https://t.co/lxz4ROfbzc

[peter ruprecht @peterruprecht_]

@ShahidA99580 Motion

[peter ruprecht @peterruprecht_]

@maverickecom workflow

[peter ruprecht @peterruprecht_]

@jasonwilliamsmd I lost my dad to pancreatic cancer, so this is honestly one of the most hopeful and amazing stories I’ve come across. I really wish Dr. Williams’ technology had been around when my dad was here, but it makes me so happy to know it’s helping other dads stick around now!

[Jason R. Williams, MD, DABR @jasonwilliamsmd]

The Part of the Cancer Story You Don’t Usually Hear https://t.co/Bn3AA4tVJX

[peter ruprecht @peterruprecht_]

@TheUltimate_AI AI

[peter ruprecht @peterruprecht_]

My first scary interaction with Grok...it literally decided to disregard to my instructions and later apologize when i asked it speak more politely in front of my child.. THIS IS KIND OF "pre SKY NET" SCARY.